Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers
- PMID: 41542929
- PMCID: PMC12809718
- DOI: 10.1002/alz.71024
Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers
Abstract
Introduction: "SuperAgers" are oldest-old adults (ages 80+) whose memory performance more closely resembles middle-aged adults. The present study examined apolipoprotein E (APOE) allele frequency in non-Hispanic Black (NHB) and non-Hispanic White (NHW) SuperAgers compared to controls and Alzheimer's disease dementia cases.
Methods: In 18,080 participants from eight cohorts, harmonized clinical diagnostics and memory, executive function, and language domain scores were used to identify SuperAgers, cases, and controls across age-defined bins.
Results: NHW SuperAgers had significantly lower frequency of APOE-ε4 alleles and higher frequency of APOE-ε2 alleles compared to all cases and controls, including oldest-old controls. Similar patterns were found in a small yet substantial sample of NHB SuperAgers; however, not all comparisons with controls reached significance.
Discussion: We demonstrated strong evidence that APOE allele frequency relates to SuperAger status. Further research is needed with a larger sample of NHB SuperAgers to determine if mechanisms conferring cognitive resilience differ across race groups.
Highlights: Apolipoprotein E (APOE) allele frequency differs between SuperAgers and cases APOE allele frequency differs between non-Hispanic White SuperAgers and controls The relationship of APOE and non-Hispanic Black SuperAger status is unclear.
Keywords: APOE genotype; Alzheimer's disease; SuperAgers; cognitive aging; cognitive resilience.
© 2026 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare no conflicts of interest. Author disclosures are available in the supporting information.
Figures
Update of
-
Evaluating the association of APOE genotype and cognitive resilience in SuperAgers.medRxiv [Preprint]. 2025 Jun 25:2025.01.07.25320117. doi: 10.1101/2025.01.07.25320117. medRxiv. 2025. Update in: Alzheimers Dement. 2026 Jan;22(1):e71024. doi: 10.1002/alz.71024. PMID: 39830268 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- UH2 NS100599/NS/NINDS NIH HHS/United States
- R01 AG021155/AG/NIA NIH HHS/United States
- P30 AG066462/AG/NIA NIH HHS/United States
- Janssen Alzheimer Immunotherapy Research & Development, LLC.
- K01 AG073584/AG/NIA NIH HHS/United States
- Alzheimer's Therapeutic Research Institute
- P20 AG068082/AG/NIA NIH HHS/United States
- P30 AG072975/AG/NIA NIH HHS/United States
- R01 AG15819/University of Southern California
- P30 AG066444/AG/NIA NIH HHS/United States
- R01 AG037639/AG/NIA NIH HHS/United States
- UH3 NS100599/NS/NINDS NIH HHS/United States
- EuroImmun
- Biogen
- P30 AG066507/AG/NIA NIH HHS/United States
- P30 AG072946/AG/NIA NIH HHS/United States
- P30 AG066518/AG/NIA NIH HHS/United States
- CAPMC/ CIHR/Canada
- R01 AG067482/AG/NIA NIH HHS/United States
- P30 AG066511/AG/NIA NIH HHS/United States
- P30 AG086404/AG/NIA NIH HHS/United States
- U24 AG072122/AG/NIA NIH HHS/United States
- P30 AG066512/AG/NIA NIH HHS/United States
- Alzheimer's Drug Discovery Foundation
- Servier
- P30 AG066515/AG/NIA NIH HHS/United States
- Lumosity
- P30 AG062421/AG/NIA NIH HHS/United States
- Bristol-Myers Squibb Company
- U01 AG024904/AG/NIA NIH HHS/United States
- Takeda Pharmaceutical Company
- U01 AG068057/AG/NIA NIH HHS/United States
- Piramal Imaging
- W81XWH-12-2-0012/the Alzheimer's Disease Neuroimaging Initiative
- ALZ/Alzheimer's Association/United States
- RF1 AG054074/AG/NIA NIH HHS/United States
- P30 AG066508/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- R01 AG0271761/the Wisconsin Registry for Alzheimer's Prevention
- Genentech, Inc.
- U24 AG056270/AG/NIA NIH HHS/United States
- P30 AG072978/AG/NIA NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- P30 AG10161/University of Southern California
- P30 AG062429/AG/NIA NIH HHS/United States
- R01 AG028786/AG/NIA NIH HHS/United States
- Araclon Biotech
- P30 AG066519/AG/NIA NIH HHS/United States
- U24 AG074855/AG/NIA NIH HHS/United States
- R01 AG027161/AG/NIA NIH HHS/United States
- R01 AG054047/AG/NIA NIH HHS/United States
- Novartis Pharmaceuticals Corporation
- Meso Scale Diagnostics, LLC.
- CereSpir, Inc.
- P30 AG072973/AG/NIA NIH HHS/United States
- Northern California Institute for Research and Education
- BioClinica, Inc.
- P30 AG062422/AG/NIA NIH HHS/United States
- R01 AG079280/AG/NIA NIH HHS/United States
- GE Healthcare
- P30 AG086401/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P30 AG066530/AG/NIA NIH HHS/United States
- Transition Therapeutics
- R01 AG059716/AG/NIA NIH HHS/United States
- R01 AG064233/AG/NIA NIH HHS/United States
- P30 AG066509/AG/NIA NIH HHS/United States
- Cogstate
- U01 AG052410/AG/NIA NIH HHS/United States
- the National Institute of Biomedical Imaging and Bioengineering
- Johnson & Johnson Pharmaceutical Research & Development LLC
- P30 AG066546/AG/NIA NIH HHS/United States
- R01 AG022018/AG/NIA NIH HHS/United States
- P30 AG072977/AG/NIA NIH HHS/United States
- NH/NIH HHS/United States
- Pfizer Inc.
- P30 AG062677/AG/NIA NIH HHS/United States
- Illinois Department of Public Health
- Elan Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- R01 AG027944/AG/NIA NIH HHS/United States
- Eli Lilly and Company
- P30 AG072958/AG/NIA NIH HHS/United States
- following: AbbVie
- P30 AG062715/AG/NIA NIH HHS/United States
- P30 AG066506/AG/NIA NIH HHS/United States
- P30 AG066468/AG/NIA NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- IXICO Ltd.
- NeuroRx Research
- The ADSP Phenotype Harmonization Consortium
- P30 AG072947/AG/NIA NIH HHS/United States
- K24 AG046373/AG/NIA NIH HHS/United States
- P30 AG072931/AG/NIA NIH HHS/United States
- P30 AG072972/AG/NIA NIH HHS/United States
- the National Institute on Aging
- P30 AG066514/AG/NIA NIH HHS/United States
- P30 AG072959/AG/NIA NIH HHS/United States
- U19 AG066567/AG/NIA NIH HHS/United States
- R01 AG056405/AG/NIA NIH HHS/United States
- Laboratory for Neuro Imaging
- Neurotrack Technologies
- Fujirebio
- Lundbeck
- P30 AG072979/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
